Zydelig (idelalisib)

pCPA File Number: 20829
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Lymphocytic Leukemia
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
pCODR 10057
pCPA Engagement Letter Issued:
Negotiation Process Concluded: